Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Astonea Labs Limited has appointed three new Additional Directors in the Non-Executive, Non-Independent category, effective 10th November 2025. The appointees are Mr. Arun Kumar Tripathi (B.Pharm, pharma/cosmetic manufacturing background), Mr. Pardeep Dalal (BA, finance experience), and Mr. Vikrant (Dairy Science, pharma/cosmetic research background). All three are aged around 39-40 years and based in Haryana. They will hold office until the next Annual General Meeting (AGM), and being Additional Directors, their appointment is subject to shareholder approval at the ensuing AGM. The company has confirmed none of them are debarred by SEBI or any other authority, and none are related to existing Directors or Key Managerial Personnel.
This is a routine board expansion that adds industry-relevant expertise (pharma manufacturing, finance, and formulation R&D) to the board. It is unlikely to have a direct material impact on stock price, but shareholder approval will be sought at the upcoming AGM.